BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Keshavarzian A, Engen P, Bonvegna S, Cilia R. The gut microbiome in Parkinson's disease: A culprit or a bystander? Prog Brain Res 2020;252:357-450. [PMID: 32247371 DOI: 10.1016/bs.pbr.2020.01.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Zapała B, Stefura T, Wójcik-Pędziwiatr M, Kabut R, Bałajewicz-Nowak M, Milewicz T, Dudek A, Stój A, Rudzińska-Bar M. Differences in the Composition of Gut Microbiota between Patients with Parkinson's Disease and Healthy Controls: A Cohort Study. J Clin Med 2021;10:5698. [PMID: 34884399 DOI: 10.3390/jcm10235698] [Reference Citation Analysis]
2 Tan AH, Hor JW, Chong CW, Lim SY. Probiotics for Parkinson's disease: Current evidence and future directions. JGH Open 2021;5:414-9. [PMID: 33860090 DOI: 10.1002/jgh3.12450] [Reference Citation Analysis]
3 Chowdhury S, Ledeen R. The Key Role of GM1 Ganglioside in Parkinson’s Disease. Biomolecules 2022;12:173. [DOI: 10.3390/biom12020173] [Reference Citation Analysis]
4 Zhao Z, Ning J, Bao XQ, Shang M, Ma J, Li G, Zhang D. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis. Microbiome 2021;9:226. [PMID: 34784980 DOI: 10.1186/s40168-021-01107-9] [Reference Citation Analysis]
5 Peng H, Yu S, Zhang Y, Yin Y, Zhou J. Intestinal Dopamine Receptor D2 is Required for Neuroprotection Against 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Dopaminergic Neurodegeneration. Neurosci Bull . [DOI: 10.1007/s12264-022-00848-3] [Reference Citation Analysis]
6 Dias Araújo Freitas FE, Carlos Batista MA, Cristina de Assis Braga D, Brandino de Oliveira L, Antunes VR, Cardoso LM. The gut-brain axis and sodium appetite: Can inflammation-related signaling influence the control of sodium intake? Appetite 2022;:106050. [PMID: 35447164 DOI: 10.1016/j.appet.2022.106050] [Reference Citation Analysis]
7 Schaeffer E, Kluge A, Böttner M, Zunke F, Cossais F, Berg D, Arnold P. Alpha Synuclein Connects the Gut-Brain Axis in Parkinson's Disease Patients - A View on Clinical Aspects, Cellular Pathology and Analytical Methodology. Front Cell Dev Biol 2020;8:573696. [PMID: 33015066 DOI: 10.3389/fcell.2020.573696] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
8 Romano S, Savva GM, Bedarf JR, Charles IG, Hildebrand F, Narbad A. Meta-analysis of the Parkinson's disease gut microbiome suggests alterations linked to intestinal inflammation. NPJ Parkinsons Dis 2021;7:27. [PMID: 33692356 DOI: 10.1038/s41531-021-00156-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 19.0] [Reference Citation Analysis]
9 Shannon KM. Gut-Derived Sterile Inflammation and Parkinson's Disease. Front Neurol 2022;13:831090. [DOI: 10.3389/fneur.2022.831090] [Reference Citation Analysis]
10 Fu S, Shih L, Wu P, Hsieh Y, Lee C, Lin S, Wang H. Exploring the Causal Effect of Constipation on Parkinson’s Disease Through Mediation Analysis of Microbial Data. Front Cell Infect Microbiol 2022;12:871710. [DOI: 10.3389/fcimb.2022.871710] [Reference Citation Analysis]
11 Mancinelli AM, Vichich JM, Zinnen AD, Hugon AM, Bondarenko V, Metzger JM, Simmons HA, Golos TG, Emborg ME. Acute Exposure to the Food-Borne Pathogen Listeria monocytogenes Does Not Induce α-Synuclein Pathology in the Colonic ENS of Nonhuman Primates. J Inflamm Res 2021;14:7265-79. [PMID: 34992416 DOI: 10.2147/JIR.S337549] [Reference Citation Analysis]
12 Tan AH, Chong CW, Lim SY, Yap IKS, Teh CSJ, Loke MF, Song SL, Tan JY, Ang BH, Tan YQ, Kho MT, Bowman J, Mahadeva S, Yong HS, Lang AE. Gut Microbial Ecosystem in Parkinson Disease: New Clinicobiological Insights from Multi-Omics. Ann Neurol 2021;89:546-59. [PMID: 33274480 DOI: 10.1002/ana.25982] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
13 Leta V, Ray Chaudhuri K, Milner O, Chung-Faye G, Metta V, Pariante CM, Borsini A. Neurogenic and anti-inflammatory effects of probiotics in Parkinson's disease: A systematic review of preclinical and clinical evidence. Brain Behav Immun 2021;98:59-73. [PMID: 34364965 DOI: 10.1016/j.bbi.2021.07.026] [Reference Citation Analysis]
14 Travagli RA, Browning KN, Camilleri M. Parkinson disease and the gut: new insights into pathogenesis and clinical relevance. Nat Rev Gastroenterol Hepatol 2020;17:673-85. [PMID: 32737460 DOI: 10.1038/s41575-020-0339-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 13.0] [Reference Citation Analysis]
15 Gebrayel P, Nicco C, Al Khodor S, Bilinski J, Caselli E, Comelli EM, Egert M, Giaroni C, Karpinski TM, Loniewski I, Mulak A, Reygner J, Samczuk P, Serino M, Sikora M, Terranegra A, Ufnal M, Villeger R, Pichon C, Konturek P, Edeas M. Microbiota medicine: towards clinical revolution. J Transl Med 2022;20. [DOI: 10.1186/s12967-022-03296-9] [Reference Citation Analysis]
16 Zheng SY, Li HX, Xu RC, Miao WT, Dai MY, Ding ST, Liu HD. Potential roles of gut microbiota and microbial metabolites in Parkinson's disease. Ageing Res Rev 2021;69:101347. [PMID: 33905953 DOI: 10.1016/j.arr.2021.101347] [Reference Citation Analysis]
17 Lubomski M, Xu X, Holmes AJ, Muller S, Yang JYH, Davis RL, Sue CM. Nutritional Intake and Gut Microbiome Composition Predict Parkinson’s Disease. Front Aging Neurosci 2022;14:881872. [DOI: 10.3389/fnagi.2022.881872] [Reference Citation Analysis]
18 Cai XT, Li H, Borch Jensen M, Maksoud E, Borneo J, Liang Y, Quake SR, Luo L, Haghighi P, Jasper H. Gut cytokines modulate olfaction through metabolic reprogramming of glia. Nature 2021;596:97-102. [PMID: 34290404 DOI: 10.1038/s41586-021-03756-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Nyholm D, Hellström PM. Effects of Helicobacter pylori on Levodopa Pharmacokinetics. J Parkinsons Dis 2021;11:61-9. [PMID: 33164946 DOI: 10.3233/JPD-202298] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
20 Cilia R, Piatti M, Cereda E, Bolliri C, Caronni S, Ferri V, Cassani E, Bonvegna S, Ferrarese C, Zecchinelli AL, Barichella M, Pezzoli G. Does Gut Microbiota Influence the Course of Parkinson's Disease? A 3-Year Prospective Exploratory Study in de novo Patients. J Parkinsons Dis 2021;11:159-70. [PMID: 33337387 DOI: 10.3233/JPD-202297] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]